当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2022-11-21 , DOI: 10.1111/apt.17306 Mojahidul Islam 1 , Jayesh Kumar Sevak 1 , Manoj Kumar Sharma 2 , Ankur Jindal 2 , Ashish Kumar Vyas 1 , Meenu Bajpai 3 , Gayatri Ramakrishna 1 , Shiv Kumar Sarin 2 , Nirupma Trehanpati 1
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2022-11-21 , DOI: 10.1111/apt.17306 Mojahidul Islam 1 , Jayesh Kumar Sevak 1 , Manoj Kumar Sharma 2 , Ankur Jindal 2 , Ashish Kumar Vyas 1 , Meenu Bajpai 3 , Gayatri Ramakrishna 1 , Shiv Kumar Sarin 2 , Nirupma Trehanpati 1
Affiliation
|
Hepatitis B surface antigen (HBsAg) seroconversion is sometimes observed in hepatitis B reactivation (rHBV), probably due to immune resetting and differentiation.
中文翻译：
乙型肝炎再激活患者乙型肝炎表面抗原血清学转换的免疫预测因子
乙型肝炎表面抗原 (HBsAg) 血清转化有时在乙型肝炎再激活 (rHBV) 中观察到，这可能是由于免疫重置和分化。
更新日期：2022-11-21
中文翻译：
乙型肝炎再激活患者乙型肝炎表面抗原血清学转换的免疫预测因子
乙型肝炎表面抗原 (HBsAg) 血清转化有时在乙型肝炎再激活 (rHBV) 中观察到，这可能是由于免疫重置和分化。
京公网安备 11010802027423号